Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 224

The DOI matches its Crossref record.

Clinical Prognostic Factors in Malignant Parotid Gland Tumors

Lima, Roberto A., Tavares, Marcos R., Dias, Fernando L., Kligerman, Jacob, Nascimento, Marilene F., Barbosa, Mauro M., Cernea, Claudio R., Soares, Jose R., Santos, Izabella C., Salviano, Scheylla·2005·Otolaryngology–Head and Neck Surgery

Abstract

OBJECTIVE: To analyze the factors in parotid malignant epithelial tumors influencing recurrences and disease‐specific survival. METHODS: We retrospectively reviewed the files of 150 patients treated at our institution, from 1974 to 1998. Twenty‐four patients were not treated by surgery and were excluded from this study. The remaining 126 patients were treated with surgery and 74 patients had postoperative radiotherapy. Thirty‐three patients were treated with parotidectomy plus neck dissection. Neck lymph node metastasis was found in 22 patients, 5 patients had occult neck metastasis, and 4 periparotid lymph nodes metastasis. The mean age was 49 years old. According to the UICC/1997 TNM Classification, 49 patients were stage I, 27 stage II, 22 stage III, and 28 stage IV. The influence of selected factors on the 10 year disease‐specific survival was analyzed using the Kaplan‐Meier actuarial method and the log‐rank test. RESULTS: Forty patients had mucoepidermoid carcinoma, 18 patients adenocarcinoma NOS, 18 patients acinic cell carcinoma, 15 patients adenoid cystic carcinoma, 11 patients malignant mixed tumor, 11 patients salivary duct carcinoma, and 13 patients other pathology. Twenty‐five patients had recurrences: 17 had local recurrences, 4 patients had neck recurrences, and 4 were loco‐regional recurrences. Five factors influenced negatively the prognosis: 1) T stage (p.00001), 2) grade (p.00001), 3) + lymph nodes (p.0007), 4) facial nerve dysfunction (p.0001), and 5) age (p.004). Patients with high‐grade tumors and high‐stage tumors had the worst prognosis according to the multivariate analysis. The 10‐year disease‐specific survival was 97% for stage I, 81% for stage II, 56% for stage III, and 20% for stage IV. CONCLUSION: The grade of the tumor and stage were the most important prognostic factor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.otohns.2005.08.001

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Metadata

Authors
Lima, R. A., Tavares, M. R., Dias, F. L., Kligerman, J., Nascimento, M. F., Barbosa, M. M., Cernea, C. R., Soares, J. R., Santos, I. C., & Salviano, S.
Venue
Otolaryngology–Head and Neck Surgery
Publisher
Wiley
Published
2005-11
Volume
133
Issue
5
Pages
702-708
ISSN
  • 0161-6439 (ISSN-L)
  • 0194-5998
  • 1097-6817
OpenAlex
W2158869829
Cited by
224
References
0
FWCI
8.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Prognostic Factors in Malignant Parotid Gland Tumors. https://app.cochat.ai/papers/10.1016/j.otohns.2005.08.001
The paper
Lima, R. A., Tavares, M. R., Dias, F. L., Kligerman, J., Nascimento, M. F., Barbosa, M. M., Cernea, C. R., Soares, J. R., Santos, I. C., & Salviano, S. (2005). Clinical Prognostic Factors in Malignant Parotid Gland Tumors. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1016/j.otohns.2005.08.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.